Olympus Corp
TSE:7733

Watchlist Manager
Olympus Corp Logo
Olympus Corp
TSE:7733
Watchlist
Price: 2 375.5 JPY 0.06% Market Closed
Market Cap: 2.8T JPY
Have any thoughts about
Olympus Corp?
Write Note

Olympus Corp
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Olympus Corp
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Olympus Corp
TSE:7733
Pre-Tax Income
ÂĄ105.6B
CAGR 3-Years
-3%
CAGR 5-Years
7%
CAGR 10-Years
9%
Terumo Corp
TSE:4543
Pre-Tax Income
ÂĄ159.5B
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
11%
Sysmex Corp
TSE:6869
Pre-Tax Income
ÂĄ79.6B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
7%
Nihon Kohden Corp
TSE:6849
Pre-Tax Income
ÂĄ18.7B
CAGR 3-Years
-20%
CAGR 5-Years
3%
CAGR 10-Years
0%
JEOL Ltd
TSE:6951
Pre-Tax Income
ÂĄ33.3B
CAGR 3-Years
65%
CAGR 5-Years
34%
CAGR 10-Years
21%
Fukuda Denshi Co Ltd
TSE:6960
Pre-Tax Income
ÂĄ24.1B
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
7%
No Stocks Found

Olympus Corp
Glance View

Market Cap
2.7T JPY
Industry
Health Care

Olympus Corporation, originating from the heart of Japan in 1919, has evolved into a global powerhouse, particularly revered for its contributions to the field of optics and imaging. Initially carving its reputation through crafting precision microscope lenses, Olympus seamlessly expanded its capabilities into the realms of endoscopy and digital imaging. This strategic pivot not only defined its legacy but firmly anchored its presence in the medical world, where it became a leader in endoscopic technology. The company adeptly leveraged its expertise to revolutionize medical diagnostics and treatment, helping medical professionals see and diagnose better—enhancing both physician dexterity and patient outcomes. Revenue for Olympus is predominantly driven by its Medical Business sector, which constitutes a significant portion of its overall profits, underscoring its transformation from a diversified manufacturer to a specialized player in healthcare technology. They are deeply committed to R&D, funneling substantial resources to innovate and bolster their portfolio in medical devices, particularly in fields like therapeutic interventions. While imaging products for consumers have historically been a notable segment, the shift toward medical technology aligns with broader market demands and ensures sustainable growth. This focus demonstrates Olympus's intent to maximize its competitive advantages, allowing it to remain at the forefront of its niche industries and effectively respond to global healthcare challenges.

Intrinsic Value
2 766.08 JPY
Undervaluation 14%
Intrinsic Value
Price

See Also

What is Olympus Corp's Pre-Tax Income?
Pre-Tax Income
105.6B JPY

Based on the financial report for Sep 30, 2024, Olympus Corp's Pre-Tax Income amounts to 105.6B JPY.

What is Olympus Corp's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
9%

Over the last year, the Pre-Tax Income growth was 15%. The average annual Pre-Tax Income growth rates for Olympus Corp have been -3% over the past three years , 7% over the past five years , and 9% over the past ten years .

Back to Top